Focus: RLS Therapeutics is a newly founded (2024) small molecule biotech company headquartered in Nashville, Tennessee, with an undisclosed employee count and early-stage development focus.
Profile data last refreshed 2h ago · AI intelligence enriched 1mo ago
Growing — net +18 jobs in 30d
20 jobs added vs 2 removed. Steady team buildout.
RLS Therapeutics presents high-risk, high-reward early-stage opportunity suitable only for founders-oriented talent willing to operate in an information-sparse environment.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for RLS Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from RLS Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles